Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Matsui, I.
Right arrow Articles by Harata, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Matsui, I.
Right arrow Articles by Harata, K.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 275, Issue 7, 4871-4879, February 18, 2000


The Molecular Structure of Hyperthermostable Aromatic Aminotransferase with Novel Substrate Specificity from Pyrococcus horikoshii*

Ikuo MatsuiDagger §, Eriko MatsuiDagger , Yukihiro SakaiDagger , Hisasi Kikuchi, Yutaka KawarabayasiDagger , Hideaki Ura||, Shin-ichi Kawaguchi||, Seiki Kuramitsu||, and Kazuaki HarataDagger §

From the Dagger  National Institute of Bioscience and Human Technology, Tsukuba, Ibaraki 305, the  National Institute of Technology and Evaluation, Ministry of International Trade and Industry, Nishihara, Shibuyaku, Tokyo, and the || Department of Biology, Graduate School of Science, Osaka University, Toyonaka, Osaka 560-0043, Japan

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Aromatic amino acid aminotransferase (ArATPh), which has a melting temperature of 120 °C, is one of the most thermostable aminotransferases yet to be discovered. The crystal structure of this aminotransferase from the hyperthermophilic archaeon Pyrococcus horikoshii was determined to a resolution of 2.1 Å. ArATPh has a homodimer structure in which each subunit is composed of two domains, in a manner similar to other well characterized aminotransferases. By the least square fit after superposing on a mesophilic ArAT, the ArATPh molecule exhibits a large deviation of the main chain coordinates, three shortened alpha -helices, an elongated loop connecting two domains, and a long loop transformed from an alpha -helix, which are all factors that are likely to contribute to its hyperthermostability. The pyridine ring of the cofactor pyridoxal 5'-phosphate covalently binding to Lys233 is stacked parallel to F121 on one side and interacts with the geminal dimethyl-CH/pi groups of Val201 on the other side. This tight stacking against the pyridine ring probably contributes to the hyperthermostability of ArATPh. Compared with other ArATs, ArATPh has a novel substrate specificity, the order of preference being Tyr > Phe > Glu > Trp > His Met > Leu > Asp > Asn. Its relatively weak activity against Asp is due to lack of an arginine residue corresponding to Arg292* (where the asterisk indicates that this is a residues supplied by the other subunit of the dimer) in pig cytosolic aspartate aminotransferase. The enzyme recognizes the aromatic substrate by hydrophobic interaction with aromatic rings (Phe121 and Tyr59*) and probably recognizes acidic substrates by a hydrophilic interaction involving a hydrogen bond network with Thr264*.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Aminotransferases have been widely applied in the large scale biosynthesis of unnatural amino acids, which are in increasing demand by the pharmaceutical industry for peptidomimic and other single-enantiomer drugs (1). These enzymes have been classified into four families (I-IV) (2). Family I includes the aspartate aminotransferases (AspATs),1 aromatic amino acid aminotransferases (ArATs), alanine ATs, and histidinol phosphate aminotransferase. All members of Family I efficiently utilize alpha -ketoglutarate as an amino donor and glutamate as an amino acceptor. Eleven residues are invariant among the enzymes belonging to Family I (2). The members of Family I are further subdivided into three subfamilies according to their amino acid sequence alignment (2, 3). Subfamily Ialpha comprises AspATs isolated from Escherichia coli, yeast, chicken, pig, and other organisms, and ArATs from prokaryotes (E. coli and Paracoccus denitrificans). In this subfamily, an arginine residue (Arg292*, according to the numbering for pig cytosolic AspAT (cAspATp) (4))2 is conserved. The Arg292* residue interacts with the omega -carboxyl moiety of the dicarboxylic substrates (5-7). The arginine residue was not found in all members of subfamily Igamma , despite the normally high degree of conservation in active site residues (2, 8, 9). Subfamily Ibeta is specialized for histidine biosynthesis (2, 4).

Recently, much research effort has been directed toward the isolation and characterization of enzymes from hyperthermophilic archaea. Interest in these enzymes has increased, because of their biotechnological potentials for novel application (10, 11) and because of the need for a better understanding of their intrinsic resistance to heat and denaturing processes. The mechanisms of their stability continue to be challenging and unresolved problems in biochemistry and biotechnology (10-13). An aspartate aminotransferase gene homolog (open reading frame identification number 1371) was identified via genome sequencing in the hyperthermophilic archaeon Pyrococcus horikoshii (14, 15). The gene (ArATPh) was expressed in E. coli, the product was purified to homogeneity, and the enzyme ArATPh was determined to be an aromatic aminotransferase belonging to subfamily Igamma . We present the first report of the molecular structure of hyperthermophilic ArAT, which is an essential step in the effort to comprehend its stabilizing mechanisms. We also discuss its novel substrate specificity and dual substrate binding mechanism for both acidic and aromatic amino acids on the basis of its active site structure.

    MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Chemicals-- The pET-11a vector and ultracompetent E. coli XL2-Blue MRF' cell were purchased from Stratagene (La Jolla, CA). The pET-15b vector and E. coli strain BL21 (DE3) were obtained from Novagen (Madison, WI). Vent DNA polymerase was purchased from New England Biolabs (Beverly, MA). Restriction enzymes were purchased from Promega and Toyobo (Osaka, Japan) and were used according to the manufacturer's recommendations. Ultrapure dNTP solution was obtained from Amersham Pharmacia Biotech. L-Cysteinsulfinic acid, bovine DNase I, beta -NADH, and malate dehydrogenase from porcine heart (mitochondrial) were purchased from Sigma. 2-Oxoglutaric acid monosodium salt and DTNB were purchased from Nacalai Tesque (Kyoto, Japan). Isopropyl-beta -D-thiogalactopyranoside was purchased from Takara Shuzo (Otsu, Shiga, Japan).

Cloning of Genes and Construction of Expression Vector-- The complete genome sequence of P. horikoshii has been reported by Kawarabayasi et al. (14, 15). Standard cloning techniques were used throughout. The aromatic aminotransferase (ArATPh) gene was amplified using polymerase chain reaction with primers having NdeI and BamHI restriction sites according to a method reported previously (16). The sequences of the primers were 5'-TTTTGTCGACTTACATATGGCGCTAAGTGACAGA-3' (underlining indicates the upper primer containing the NdeI site) and 5'-TTTTGGTACCTTTGGATCCTTAACCAAGGATTTAAACTAG-3' (underlining indicates the lower primer containing the BamHI site). The amplified gene was digested by NdeI and BamHI, and the digested fragment coding for ArATPh was inserted in an expression vector pET-11a cut with the same restriction enzymes. The nucleotide sequence of the inserted gene was verified by sequencing on an Applied Biosystems 373A DNA sequencer (Taq DyeDeoxy Terminator Cycle Sequencing Kit, Perkin-Elmer).

Overexpression and Purification of Recombinant Protein-- The cloned gene was expressed using the pET-11a vector system in the host E. coli strain BL21 (DE3) according to the manufacturer's instructions. The host cells were transformed with the constructed pET-11a/ArATPh plasmid, after which the production of the protein was performed according to the method described previously (16). The concentration of the expressed protein was determined using a Coomassie protein assay reagent (Pierce) and utilizing bovine serum albumin as the standard protein. The crude enzyme solution was prepared from the transformant E. coli, and the enzyme was purified using chromatography in a HiTrap Q column (Amersham Pharmacia Biotech) and a HiLoad Superdex 200 column (Amersham Pharmacia Biotech) (16). The purity of the enzyme samples was analyzed using SDS-polyacrylamide gel electrophoresis (17) and isoelectric focusing using a PhastSystem (Amersham Pharmacia Biotech). Protein sequencing of recombinant ArATPh was performed by Takara Shuzo Co. Ltd. (Otsu, Shiga, Japan) using a protein sequencer PSQ-1 (Shimazu, Japan).

Pre-steady-state Kinetic Studies of Half-transamination Reactions-- Aliphatic amino acid substrates with unbranched side chains were used to estimate the hydrophobic substrate specificities of the aminotransferase. We used L-form amino acids for the sC3-sC6 substrates and DL-isoforms for the sC7-sC9 substrates (18); the aminotransferase tested here cannot use D-form amino acids as substrates. All measurements were carried out at pH 8.0 and 25 °C. The buffer solution contained 50 mM HEPES with 100 mM KCl and 10 mM EDTA.

The slow reaction was followed spectrophotometrically by monitoring the change in absorption of the bound coenzyme at 380 nm. When the kapp value was directly proportional to the substrate concentration, the kmax/Kd value was calculated from the following equation (18, 19).
k<SUB><UP>app</UP></SUB>=(k<SUB><UP>max</UP></SUB>/K<SUB>d</SUB>)[<UP>S</UP>] (Eq. 1)
Thus, the catalytic efficiency, kmax/Kd, was given by kapp/[S] for these substrates. The rapid reactions were followed using stopped flow spectrophotometers from Union Giken (model RA-401) or Applied Photophysics (model SX-17MW). The reaction curves conformed to a single-exponential process. The free energy differences (Delta GTnot equal ) between the transition state and unbound enzyme plus substrate for various substrates were calculated using the following equation (19, 20).
&Dgr;G<SUP><UP>≠</UP></SUP><SUB><UP>T</UP></SUB>=RT(<UP>ln</UP>(k<SUB><UP>B</UP></SUB>T/h)−<UP>ln</UP>(k<SUB><UP>max</UP></SUB>/K<SUB>d</SUB>)) (Eq. 2)
where R is the gas constant, T is the absolute temperature, kB is the Boltzmann constant, and h is the Planck constant.

Temperature Dependence of Activity for Overall Transamination Reaction-- The overall transamination reaction for the acidic substrate aspartate was measured spectrophotometrically at 340 nm using a coupled assay with malate dehydrogenase and NADH at pH 8.0 and 25 °C (20, 21), and the steady-state kinetics parameters, Km and kcat, were determined. The reaction mixtures contained 50 mM HEPES, 100 mM KCl, 0.01 mM EDTA, 0.1 mM NADH, 2.5 units/ml malate dehydrogenase, 1 µM ArATPh, and various concentrations of L-aspartate or 2-oxoglutarate. The activity of the hydrophobic substrate phenylalanine was measured at pH 8.0 and 25 °C. The product formation of the phenylpyruvate was monitored at 280 nm using the molar extinction coefficient difference of 450 cm-1 M-1 between phenylpyruvate and phenylalanine (22). The reaction mixture contained 50 mM HEPES, 100 mM KCl, 20 nM ArATPh, and various concentrations of L-phenylalanine or 2-oxoglutarate.

To determine temperature dependence, the activities for five sets of substrates, tryptophan-2-ketoglutarate (Trp-2OG), tryptophan-phenylpyruvate (Trp-KetoPhe), histidine-2-ketoglutarate (His-2OG), histidine-phenylpyruvate (His-KetoPhe), and glutamate-phenylpyruvate (Glu-KetoPhe) were measured at different temperatures (25-90 °C) at pH 8.0. Based on the following molar extinction coefficients of 2-oxo acid derivatives, the concentration of the enzymatic products were calculated: at 310 nm, 24.5 and 3200 cm-1 M-1 for 2OG and 3-indolepyruvate, respectively, and at 280 nm, 21 and 450 cm-1 M-1 for 2OG and KetoPhe (22), respectively. The product from His was monitored at 293 nm using a coefficient difference of 3050 cm-1 M-1 obtained to subtract the spectrum for the reaction of histidine with the PLP enzyme from that of the pyridoxamine 5'-phosphate enzyme (23). The reaction mixture contained 50 mM HEPES, 100 mM KCl, 20 nM ArATPh, and various concentrations of amino acids or keto-acids.

Optimum Temperature and Thermostability for ArATPh Reaction-- The optimum temperature for ArATPh activity was measured as described previously (24). The enzyme reaction was carried out in a solution (3.05 ml) containing ArATPh (3.8 nM), L-cysteinsulfinic acid (12.8 mM), 2-oxoglutaric acid (2.0 mM), EDTA (98 µM), and DTNB (1.5 mM) in 50 mM phosphate buffer (pH 6.5) at 30-98 °C, and the rate of increase in absorbance at 412 nm because of the reduction of DTNB was monitored for 5 min. For controls, the reactions were performed under the same conditions but without the enzyme.

To determine thermostability, the enzyme solutions (0.1 mg/ml) in 20 mM phosphate buffer (pH 6.5) were incubated at 95 °C for 90 and 120 min and then autoclaved in sealed Eppendorf tubes at 110 °C for 5, 15, 30, and 90 min. The heated enzymes were assayed in duplicate at 90 °C, as described elsewhere (24).

Spectroscopy of Coenzyme-- To investigate the ionization of the internal Schiff base, the absorption spectra of the enzyme at a protein concentration of approximately 20 µM in a 1-cm cell were measured at 25 °C using a Hitachi spectrophotometer (model U-3000). The buffer solution was comprised of 100 mM KCl, 0.01 mM EDTA, and a buffer component of 50 mM MES, 50 mM PIPES, or 50 mM HEPES.

pH Stability-- The gross conformation and pH stability of ArATPh were studied using CD spectroscopy. The CD spectra of ArATPh, at a protein concentration of approximately 0.1 mg/ml in a 1-mm cell, were measured at 25 °C using a spectropolarimeter (J-720W, Jasco, Japan). The solution was comprised of 100 mM KCl and a buffer component of 50 mM acetate, 20 mM phosphate, 50 mM borate, or 20 mM carbonate.

Scanning Calorimetry-- The thermal denaturation curve of ArATPh was measured using a Nano Differential Scanning Calorimeter (CSC5100, Calorimetry Science Co.). Before measurement, the enzyme solution (1 mg/ml) was dialyzed against 20 mM phosphate buffer, pH 6.5, and degassed for 15 min using an aspirator. The sample cell was filled with the degassed enzyme solution, and the reference cell was filled with the outer solution from the dialysis. The measurement was performed at a temperature range of 0-125 °C. A scan rate of 1 K/min was used throughout. The denaturation profile was analyzed using Nano differential scanning calorimetry CpCalc data analysis software (Calorimetry Science Co.).

Structure Determination, Refinement, and Model Building-- Crystals were obtained using the hanging drop vapor diffusion technique. An equi-volume of 3 M 1,6-hexane-di-ol solution at pH 7.5 (100 mM HEPES buffer) containing 10 mM MgCl2 was added to a protein solution containing 1.6% ArATPh and 20 µM pyridoxal-5'-phosphate and a 10-µl droplet of the solution was equilibrated with 1 ml of a 3 M 1,6-hexane-di-ol solution. Crystals were grown at room temperature for 1 week. X-ray diffraction experiments were carried out on an Enraf FAST differactometer equipped with a FR571 generator (40 kV, 50 mA; focal spot size, 0.2 mm), and intensity data were collected at a resolution of 2.1 Å for the native crystal and at 3.0 Å for the heavy atom derivatives.

The structure was determined using the multiple isomorphous replacement method. A structure model was built on an electron density map calculated with multiple isomorphous replacement phases with a figure of merit of 0.93. The amino acid sequence was unambiguously traced on the map and most of the side chains were identified. The structure was refined to a resolution of 2.1 Å using X-PLOR (25). All coordinates have been deposited with the RCSB Protein Data Bank as entry 1DJU. In the substrate-binding model, the coordinates of ArATPh with water molecules were fixed, but the torsion angles of the substrates were changed to find the best fitting configuration to the enzyme.

Sequence Alignment and Phylogenetic Tree-- We performed a sequence alignment of 11 aminotransferases within subfamily 1gamma using the GeneWorks program (IntelliGenetics, Inc., Mountain View, CA) based on a PAM-250 scoring matrix. The compared enzymes were as follows: ArATPh, AspATs from thermophilic Bacillus sp. (26), Thermus thermophilus HB8 (8), Rhizobium meliloti (27), Bacillus subtilis (28), Methanococcus jannaschii (29), and Sulfolobus solfataricus (30); tyrosine ATs from human (31), rat (32), and Trypanosoma cruzi (33); and alanine ATs from human (34), rat (35), and Panicum miliaceum (36). Phylogenetic trees for the same sequences were constructed using the GeneWorks program based on the unweighted pair group method with an arithmetic mean (37).

    RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Sequence Alignment and Phylogenetic Tree of ArATPh-- Because we were unable to construct a united alignment among aminotransferases belonging to the subfamilies 1alpha , 1beta , and 1gamma from P. horikoshii, other archaea, bacteria, and eukaryotes because of a lack of similarity between each subfamily, we made the alignment using 11 candidates belonging to subfamily 1gamma to identify its conserved residues. The best alignment was obtained with the five thermophilic aminotransferases shown in Fig. 1. ArATPh showed poor identity to E. coli AspAT (AspATEc) (38), E. coli ArAT (ArATEc) (39, 40), and P. denitrificans ArAT (ArATPd) (41), which are well known members of subfamily Ialpha . According to these results, ArATPh was nominated to the aminotransferase subfamily Igamma (2, 3). Furthermore, ArATPh was closer to the thermophilic AspATs than to the tyrosine ATs from eukaryotes in subfamily Igamma .


View larger version (66K):
[in this window]
[in a new window]
 
Fig. 1.   Aligned amino acid sequences of five thermophilic aminotransferases belonging to subfamily Igamma . Thermus, T. thermophilus HB8 (8); Bac.sp, thermophilic Bacillus sp. YM-2 (26); Metha2, M. jannaschii isozyme 2 (29); Ph, P. horikoshii (present paper); Sulfo, S. solfataricus (30). The conserved residues, identified automatically by the GeneWorks program, are shown in open boxes. Large capital letters indicate the completely conserved residues among the 11 candidates listed under "Materials and Methods." The numbering is according to cAspATp (4). R292 indicates the position corresponding to Arg292* in cAspATp.

Overexpression, Purification, and Oligomeric Structure of Recombinant ArATPh-- The ArATPh gene was abundantly expressed in E. coli BL21 (DE3), and the recombinant ArATPh comprised 30% of the total protein. After heat treatment at 80 °C for 15 min, which removed most of the endogenous E. coli proteins, the protein was purified to homogeneity by sequential chromatography on HiTrap Q and HiLoad Superdex 200 columns. The final preparation of the ArATPh displayed a single band (42 kDa) on SDS-polyacrylamide gel electrophoresis. Isoelectric focusing indicated a pI value of 5.2 for ArATPh. The N-terminal sequence of the recombinant ArATPh was ALSDRLELVSASEIRKL, which was identical to that deduced from the DNA sequence without the initial methionine residue. The enzyme had an apparent molecular mass of 56 kDa as estimated by gel filtration on a calibrated TSK gel G2000SWXL column, and a subunit molecular mass of 42 kDa as estimated by SDS-polyacrylamide gel electrophoresis. This suggests that it has a dimeric structure similar to other aminotransferases (24, 34, 42-45).

Optimum Temperature of the Recombinant ArATPh-- The optimum temperature of this enzyme was 90 °C, which represents an extreme thermophilic characteristic. The kapp of ArATPh increased steadily in the range of the temperature studied here. The kapp for L-cysteinsulfinic acid and 2-ketoglutaric acid as substrates was 1.39 × 102 s-1 at 90 °C and pH 6.5. Like several other thermophilic enzymes (46-48), the recombinant ArATPh shows a thermal transition in conformation as indicated in Arrhenius plots near 70 °C (data not shown).

Substrate Specificity-- Delta GTnot equal , the free energy difference between the unbound enzyme plus substrate (E + S) and the transition state (ESnot equal ), was calculated for various substrates using Equation 1 or 2. A smaller Delta GTnot equal value indicates higher enzyme activity. As shown in Table I, Tyr is the best substrate having a kmax/Kd (M-1 s-1) value of 1.2 × 105. Three aromatic amino acids (Tyr, Phe, and Trp) and Glu are good substrates for ArATPh, whereas Asp is a poor substrate having a kmax/Kd (M-1 s-1) value of 9.1. ArATPh showed moderate activity on His. The activity of ArATPh toward a series of aliphatic substrates with straight side chains was enhanced as the side chain length increased. The activity of ArATPh was maximal for an 8-carbon substrate (2-amino octanoic acid).

                              
View this table:
[in this window]
[in a new window]
 
Table I
The kmax/Kd values of ArATPh for the half-transamination reactions with a series of substrates at pH 8.0 and 25 °C
The chain lengths of the straight substrate are shown in parentheses.

Comparison of the Substrate Specificity for ArATs from Different Origins-- The steady-state kinetic parameters of ArATPh using an overall transamination reaction between 2OG and Asp or between 2OG and Phe were measured at 25 °C (the upper section of Table II). The enzyme activity against Phe was high with a kcat/Km value of 5.2 × 103 M-1 s-1, but the activity against Asp was very low (2.2 M-1 s-1). The difference between these kcat/Km values was on the order of 103, whereas the difference for ArATEc (from E. coli) and ArATPd (from P. denitrificans) was approximately 10-fold. At the optimum reaction temperature of 90 °C, ArATPh has approximately a 102- and 10-fold higher activity for His and Glu, respectively, than does ArATEc or ArATPd at 25 °C (Table II). This indicates that Glu is the best acidic substrate for ArATPh.

                              
View this table:
[in this window]
[in a new window]
 
Table II
Comparison of the kinetic parameters (kcat/Km s-1 M-1) of the overall transamination reactions at pH 8.0 among ArATs from hyperthermophilic and mesophilic organisms
The reaction temperatures are shown in parentheses.

Spectroscopic Properties of the Enzyme-bound Coenzymes PLP and Pyridoxamine 5'-Phosphate-- An internal Schiff base is formed between Lys233 (corresponding to Lys258 in cAspATp) and the aldehyde group of the coenzyme PLP. The reaction produces a spectral change in the visible absorption region. Changes in the apparent molar absorption coefficients for the PLP form enzyme at 420 and 370 nm were plotted against pH. The Schiff base pKa value was determined to be 5.1.

Three-dimensional Structure of ArATPh-- The space group of the protein crystal is P212121, and the cell dimensions are a = 64.01, b = 124.87, and c = 128.78 Å. The structure was solved using the multiple isomorphous replacement method at a resolution of 3.0 Å using four heavy atom derivatives: K2PtCl4, methyl mercury chloride, p-chloromercuribenzenesulfonic acid, and mersalyl acid. These data are presented in Table III. The structure was refined at 2.1 Å resolution to the R value of 0.185 and Rfree of 0.254, respectively. The root mean square deviations of bond distances and angles from their ideal values were 0.017 Å and 3.24°, respectively. The (phi , psi ) values for all the amino acid residues except Thr264 fell in a normal region in the Ramachandran plot (data not shown). The crystal having a Vm = 2.9 Å3/Da contains two molecules related with local 2-fold symmetry in an asymmetric unit. ArATPh has a dimer structure (Fig. 2). One dimer molecule has two active sites, and each active site binds one PLP. In both subunits, the N-terminal region of residues 2-11 form a short alpha -helix, but region 12-26 is missing in the final structure model because no significant electron density was observed in the 2Fo - Fc and Fo - Fc maps for the region (Fig. 3). The molecule consists of two domains. The large domain has a alpha /beta structure comprised of six alpha -helices (H3-H8) and seven beta -strands (S1-S7), as assigned by the program DSSP (49). The strands form a twisted sheet structure, on both sides of which helices are arranged. The small domain consists of three alpha -helices (H10-H12) and a beta -strand (S8). A long alpha -helix (H10) links to the large domain via an alpha -helix (H9).

                              
View this table:
[in this window]
[in a new window]
 
Table III
Summary of data collection and phasing


View larger version (46K):
[in this window]
[in a new window]
 
Fig. 2.   The crystal structure of ArATPh. Calpha tracing of ArATPh dimer. Subunits A and B are colored red and blue, respectively. The PLP molecules are represented by a ball-and-stick model. The figure was produced using the program Turbo-Frodo.


View larger version (44K):
[in this window]
[in a new window]
 
Fig. 3.   The folding topology of the monomer of ArATPh. A, alpha -helices, beta -strands, and loops are colored red, blue, and yellow, respectively. The green alpha -helix corresponds to the N-terminal alpha -helix followed by the disordered region. The alpha -helices and beta -strands of the alpha /beta structure are numbered from the N terminus. The PLP molecules are represented by a space-filling model. The figure produced using the program Turbo-Frodo. B, topology diagram of ArATPh. alpha -Helices are shown as cylinders (red), beta -strands are arrows (green), and the numbering is the same as that in A. The sequential numbers of the first and last residues in each secondary structure element are indicated.

The molecular replacement method using the structures AspATEc, ArATPd, and cAspATp as templates (6, 7, 50) was not successful for solving the ArATPh structure because of poor identity of the primary sequences and a large deviation in the main chain coordinates. By the least square fit after superposing ArATPh on ArATPd, only 295 pairs of corresponding amino acid residues were present in the Calpha -Calpha distance less than 3 Å, and their root mean square deviation was 2.0 Å. Several structural differences were observed between ArATPh and ArATPd as shown in Fig. 4. The 5th, 11th, and 13th alpha -helices of ArATPd are shorten by several amino acid residues in ArATPh, corresponding to H4, H8, and H10, respectively. Interestingly, the 9th alpha -helix (from Tyr225 to Val250) in the ArATPd molecule is transformed into a long loop (from Tyr202 to Phe222) between S5 and S6 of ArATPh. A loop (Val345-Ser364) between H11 and S8 of the small domain of ArATPh covers one end of the cleft formed at the interface between the large and small domains, although the corresponding loop is shorter in the ArATPd molecule and is unable to form a lid on the cleft.


View larger version (36K):
[in this window]
[in a new window]
 
Fig. 4.   Superimposition of ArATPh (green) on ArATPd (red) (7). The figure was produced using the program Turbo-Frodo. The PLP molecule of ArATPh is represented by a space-filling model.

As shown in Figs. 5 and 6, PLP is positioned at the bottom of the active site and forms an internal aldimine bond (Schiff base linkage) with the catalytic residue Lys233 (corresponding to K258 in cAspATp). The phosphate moiety of PLP forms hydrogen bonds with Oeta of Tyr59* (Tyr70* in cAspATp), N of Ala96 (Thr109 in cAspATp), Ogamma of Ser232 (Ala257 in cAspATp), and Neta 1 and Neta 2 of Arg241 (Arg266 in cAspATp; Fig. 5A). The pyridine ring of PLP interacts with both methyl groups of Val201 (Ala224 in cAspATp) on one side, and on the other side with the phenyl ring of Phe121 (Trp140 in cAspATp), by stacking interaction. The 0-3 atom on the pyridine ring of PLP forms direct hydrogen bonds with the side chains of Asn171 (Asn194 in cAspATp) and Tyr202 (Tyr225 in cAspATp). The N1 atom on the pyridine ring forms a hydrogen bond with the side chain of Asp199 (Asp222 in cAspATp). Thus, PLP is fixed tightly at the bottom of the active center.


View larger version (28K):
[in this window]
[in a new window]
 
Fig. 5.   The PLP binding structure of ArATPh. A, the stereoview for the superposition of ArATPh (red) and AspATEc (blue) by the PLP fitting. Although the overall structure of AspATEc including the PLP binding profile (6) is quite similar to that of ArATPd (7), the AspATEc was selected as a reference structure for the superposition because of its general popularity historically. The residue numbers indicate the positions in the ArATPh molecule (red). Dotted lines indicate the hydrogen bonds in ArATPh (red). B, nomenclature of atoms for PLP.


View larger version (28K):
[in this window]
[in a new window]
 
Fig. 6.   The substrate-binding model for ArATPh represented by stereoview. The front view of the active site with Tyr. The model structure is presented in a sphere with a 15-Å radius surrounding the substrate. The subunits A and B are colored green and pink, respectively. The substrates and PLP are colored blue and red, respectively. The possible hydrogen bonds are represented as dashed lines. The yellow figure, 3.4, indicates the distance (Å) between the internal aldimine bond and the alpha -amino group of Tyr.

Gross Conformation and pH Stability-- The gross conformation and pH stability of ArATPh were studied using CD spectroscopy at 25 °C. The CD spectrum in the region between 200 and 250 nm exhibited double negative minima at 209 and 223, which are characteristic of an alpha -helical structure (data not shown). The alpha -helical content is estimated to be approximately 40%, according to the method of Chen et al. (51). The enzyme is stable between pH 4 and 11 for 24 h at 25 °C.

Heat Stability-- The residual ArATPh activity remaining after heating was measured to determine the half-life of the enzyme at 95 and 110 °C. The half-life of ArATPh is 30 min at 110 °C, and the enzyme is stable at 95 °C in 20 mM phosphate buffer (pH 6.5).

The heat capacity change of ArATPh was measured using differential scanning calorimetry from 0 to 125 °C at pH 6.5. The heat capacity change was only observed during the first scan in the differential scanning calorimetry measurement, indicating that the heat denaturation profile of ArATPh is due to an irreversible denaturation process. The profile showed one major peak at 120.1 °C. The molar enthalpy change, Delta H, was calculated to be 2.4 × 103 kJ/mol for the homodimer.

    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Structural Elements Providing Hyperthermostability on ArATPh-- ArATPh is one of the most thermostable aminotransferases ever to be purified (52), having a melting temperature of 120 °C. ArATPh is a homodimer in which each subunit is constituted of two domains, similar to other well characterized aminotransferases, such as AspATEc, ArATPd, and cAspATp (6, 7, 50). However, its structure could not be solved by the molecular replacement method because of a poor sequence similarity, large deviation in the main chain coordinates, and local changes in the secondary structure, including three shortened alpha -helices and a long loop transformed from an alpha -helix (Fig. 4). Another unique characteristic is its elongated loop between H11 and S8 (Figs. 3 and 4). The loop intimately connects two domains and covers one end of the cleft formed at the interface of the two domains. Because numerous hydrophobic residues were observed inside the cleft, the elongated loop, which closely binds the two domains and acts like a lid to shield the cleft from solvents, might be one of the factors that account for the hyperthermostability of ArATPh.

On the basis of the ArATPh structures, the surface area for one amino acid residue was calculated by dividing the accessible surface area of the dimer by total residue numbers to evaluate molecular compactness. The values of ArATPh and ArATPd are 28.0 and 33.6 Å3, respectively. The lower surface area for one residue of ArATPh molecule might be due to tight packing of the polypeptide chain into the homodimer structure. Another prominent difference in ArATPh is the large number of charged residues (Asp, Glu, Lys, and Arg) on its molecular surface compared with the ArATPd. The occupancy of the charged residues in the accessible surface area of ArATPh and ArATPd molecules are 73.3 and 48.1%, respectively. On the contrary, the frequency of polar contacts less than 3.3 Å, including hydrogen bond and ion pair among these charged residues on the surface is decreased to 36.0% for ArATPh in comparison with the value, 51.3%, of ArATPd. The accessible surface of ArATPh has higher hydrophilicity with a lower number of ion pairs than that of ArATPd. The compact packing and the remarkably water-attractive surface of ArATPh are probably major factors contributing to its hyperthermostability.

The PLP molecule of ArATPh is fixed tightly with nine hydrogen bonds at the bottom of the active site cleft (Fig. 5A). One side of the pyridine ring of PLP interacts with the geminal dimethyl groups of Val201 (Ala224 in cAspATp), whereas the other side is stacked parallel with the phenyl ring of Phe121 (Trp140 in cAspATp). In AspATEc, the methyl group of Ala224 interacts with the pyridine ring of PLP on one side, and on the other side, the pyridine ring stacks to Trp140 with a 20° inclination angle. In the thermophilic enzymes of subfamily Igamma , valine or isoleucine is found at the position corresponding to Val201 of ArATPh, whereas the residue is replaced with Ala in the mesophilic enzymes of subfamily Ialpha (2, 3). The interaction of Ala with PLP should be weaker than those of V/I in thermophilic aminotransferases because of the lack of a geminal dimethyl-CH/pi interaction (53). In subfamily Igamma of the thermophilic archaea (Fig. 1), the phenyl ring of Phe or Tyr, corresponding to Phe121 in ArATPh, always stacks to the pyridine ring of PLP. In subfamily Ialpha from the mesophilic organisms and subfamily Igamma from the thermophilic prokaryotes, these residues are replaced by tryptophan, which has a bulkier side chain with a wider surface area than does the phenyl ring (2). Consequently, a combination of the Phe121 and Val201 residues stacking tightly to the pyridine ring of PLP may contribute to the hyperthermophilic properties of ArATPh. Further crystallographic studies are in progress to better understand the mechanisms underlying the hyperthermostability of this enzyme.

PLP-binding Structure of ArATPh-- In the PLP molecule of ArATPh, the number of hydrogen bonds fixing the phosphate moiety is reduced from six to five (Fig. 5A), because of replacement of the Ser255 residue, which is conserved in both AspATEc and ArATPd (6, 7). The large conformational change of the phosphate moiety of PLP is induced by a shift in the side chains of Ala96, Ser232, and Arg241 from the corresponding residues in AspATEc. The phosphate moiety moves parallel to the plane of the pyridine ring of PLP, whereas the pyridine ring is conserved at the same position as in AspATEc. The movement of the phosphate moiety in the opposite direction might be a positive adjustment of the cofactor to compensate for changes in the secondary structure that account for its hyperthermostability. Interestingly, the Oeta position of Tyr202 in ArATPh is almost identical to that of the corresponding Tyr225 residue of AspATEc (Fig. 5A), whereas the coordinates of the main chain parts in both Tyr residues are shifted by more than 2 Å. The Tyr residues of both ArATPh and AspATEc are close enough to form a hydrogen bond with O3H of PLP. The position of the omega -carboxyl of Asp199 forming a hydrogen bond with N1H of PLP is also identical to that of Asp222 of AspATEc. These results strongly indicate that the pyridine ring must be fixed precisely at the conserved position in the active center of ArATs to make the cofactor fully active, although the phosphate moiety can be positioned according to the steric requirements. The Oeta of the Tyr202 residue of ArATPh can also form a hydrogen bond with the imino group of the Schiff base. The angle of the imino proton on the C=N plane of ArATPh is sufficient to form a hydrogen bond with Tyr202; however, the corresponding angle in AspATEc seems less suitable to form a hydrogen bond with Tyr225 (Fig. 5A). The pKa of the Schiff base of ArATPh was determined to be 5.1, which is the lowest value ever reported; the pKa values of AspATEc, T. thermophilus AspAT, and ArATEc were reported to be 6.8 (54), 6.1 (8), and 6.65 (55), respectively. This low pKa value is probably due to rotation of the C=N plane of the Schiff base against the pyridine ring of PLP to control hydrogen bonding between the imino group and the Tyr202 residue and may also be due to the unique environment around the PLP molecule caused by changes in the residues stacked to PLP (Fig. 5A).

Active Site Structure and Substrate Binding Models-- The active site structure with the best substrate, Tyr, is shown in Fig. 6. The alpha -carboxylate of Tyr was fixed at the active site by two salt bridges with Arg362 (corresponding to R386 in cAspATp) and three hydrogen bonds with Gly34, Asn171, and Tyr320. The phenyl ring of Tyr and the aromatic group of Phe121 undergo an energetically favorable "edge-to-face" interaction (56), and the aromatic ring of Tyr59* is located very closely, but not in parallel, to the phenyl ring of Tyr. Thus, the best substrate can be trapped in the hydrophobic pocket formed by Phe121, Tyr59*, the pyridine ring of PLP, Met260* (corresponding to Arg292* in cAspATp), and Val122 (Glu141 in cAspATp). In this binding model, the OH group of Tyr is located at a distance sufficient to form hydrogen bonds with Ogamma 1 of Thr264* (Ser296* in cAspATp) and with the phosphate moiety of PLP. The internal aldimine bond between PLP and Lys233 (corresponding to Lys258 in cAspATp) is located so close that a new external aldimine bond can be formed between PLP and the alpha -amino group of Tyr.

Another binding model was formed with Glu, one of the best acidic substrates. A water molecule (Xaa126*) is present at the center of three adjacent groups: the gamma -carboxyl of Glu, the Ogamma 1H of Thr264*, and the phosphate residue of PLP. The proximity (within 3 Å) of the water molecule and the adjacent residues allows formation of a hydrogen-bond network among them. The water molecule (Xaa126*) may be important in binding Glu to the active center, as indicated by the reportedly complex structure of ArATPd with maleate (7). Furthermore, the gamma -carboxyl group of Glu is parallel to the phenyl ring of Tyr59*, suggesting a van der Waals' interaction between the two groups. This sort of weak interaction may be important for the recognition of C5 substrates (Glu and 2OG) in amino acid aminotransferases, because the Y70*S mutant of AspATEc is reportedly less active against these substrates (57). The phenyl ring at position 70 is essential for the recognition of the Glu-2OG pair as substrates. Hence, in the binding model of ArATPh, both ends of the acidic substrate, Glu, are fixed at the active center of the enzyme by three major interactions: 1) salt bridges between Arg362 and the alpha -carboxylate of Glu, 2) two hydrogen bonds located between Gly34 and the alpha -carboxylate, and between Gly34 and alpha -amino groups of the substrate, and 3) the capturing of the gamma -carboxylate by the hydrogen bond network through the water molecule Xaa126* and by a weak interaction with Tyr59*. The low activity against Asp is explained in two ways: 1) the lack of an arginine residue corresponding to Arg292* of cAspATp, which interacts with the distal carboxylate of the acidic substrate and 2) the lack of a hydrogen bond network through the water molecule Xaa126* and no interaction with Tyr59*, because of a lack of one methylene unit at the gamma  position.

Substrate Specificity of ArATPh-- As shown in Tables I and II, ArATPh prefers the substrates in the following order in kmax/Kd: Tyr > Phe > Glu > Trp > His Met > Leu > Asp > Asn. The substrate specificity differs from those of the mesophilic ArATs, including ArATPd, with the preference in kcat/Km being Tyr > Phe = Asp > Trp > Glu (41). Thermostable ArATs from Pyrococcus furiosus and Methanococcus aeolicus were also reported to have distinct substrate specificity in kcat/Km: Phe > Trp > Tyr (52, 58). Consequently, ArATPh has a novel substrate specificity compared with other ArATs.

Aminotransferases are increasingly applied to the large scale synthesis of unnatural and nonproteinogenic amino acids (1). Typically exhibiting relaxed substrate specificity, rapid reaction rates, and no need for cofactor regeneration, they possess many characteristics that make them useful for biocatalysis. Because of its novel substrate specificity and high level of resistance to organic solvents (data not shown), ArATPh will continue to be a useful biocatalysis for the synthesis of unnatural compounds.

    ACKNOWLEDGEMENTS

We thank Miyuki Ishimura for assistance with the differential scanning calorimetry analysis and valuable discussions. Koichi Honda is gratefully acknowledged for his practical advice and valuable discussions.

    FOOTNOTES

* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The atomic coordinates and structure factors (code 1DJU) have been deposited in the Protein Data Bank, Brookhaven National Laboratory, Upton, NY.

§ To whom correspondence should be addressed. For I. M., Tel.: 81-298-546142; Fax: 81-298-546151 and for K. H., Tel.: 81-298-546194; Fax: 81-298-546194.

2 Asterisks after the residue number indicate the residues supplied by the other subunit of the dimer.

    ABBREVIATIONS

The abbreviations used are: AspAT, aspartate aminotransferase; AT, aminotransferase; ArATPh, aromatic amino acid AT from P. horikoshii; cAspATp, pig cytosolic AspAT; AspATEc, E. coli AspAT; ArATEc, E. coli ArAT; ArATPd, P. denitrificans ArAT; PLP, pyridoxal 5'-phosphate; KetoPhe, phenylpyruvate; 2OG, 2-oxoglutaric acid; DTNB, 5,5'-dithiobis (2-nitrobenzoic acid); MES, 2-(N-morpholino)ethanesulfonic acid; PIPES, 1,4-piperazinediethanesulfonic acid.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

1. Taylor, P. P., Pantaleone, D. P., Senkpeil, R. F., and Fotheringham, I. G. (1998) Trends Biotechnol. 16, 412-418[CrossRef][Medline] [Order article via Infotrieve]
2. Mehta, P. K., Hale, T. I., and Christen, P. (1993) Eur. J. Biochem. 214, 549-561[Medline] [Order article via Infotrieve]
3. Jensen, R. A., and Gu, U. (1996) J. Bacteriol. 178, 2161-2171[Free Full Text]
4. Ovchinnikov, Yu. A., Egorov, C. A., Aldanova, N. A., Feigina, M. Yu., Lipkin, V. M., Abdulaev, N. G., Grishin, E. V., Kiselev, A. P., Modyanov, N. N., Braunstein, A. E., Polyanovsky, O. L., and Nosikov, V. V. (1973) FEBS Lett. 29, 31-34[CrossRef][Medline] [Order article via Infotrieve]
5. Kirsch, J. F., Eichele, G., Ford, G. C., Vincent, M. G., Janonius, J. N., Gehring, H., and Christen, P. (1984) J. Mol. Biol. 174, 497-525[CrossRef][Medline] [Order article via Infotrieve]
6. Okamoto, A., Higuchi, T., Hirotsu, K., Kuramitsu, S., and Kagamiyama, H. (1994) J. Biochem. (Tokyo) 116, 95-107[Abstract/Free Full Text]
7. Okamoto, A., Nakai, Y., Hayashi, H., Hirotsu, K., and Kagamiyama, H. (1998) J. Mol. Biol. 280, 443-561[CrossRef][Medline] [Order article via Infotrieve]
8. Okamoto, A., Kato, R., Masui, R., Yamagishi, A., Oshima, T., and Kuramitsu, S. (1996) J. Biochem. (Tokyo) 119, 135-144[Abstract/Free Full Text]
9. Birolo, L., Arnone, M. I., Cubellis, M. V., Andreotti, G., Nitti, G., Marino, G., and Sannia, G. (1991) Biochim. Biophys. Acta 1080, 198-204[CrossRef][Medline] [Order article via Infotrieve]
10. Cowan, D. A., Daniel, R. M., and Morgan, H. W. (1985) Trends Biotechnol. 3, 68-72[CrossRef]
11. Cowan, D. A. (1992) Trends Biotechnol. 10, 315-332[CrossRef][Medline] [Order article via Infotrieve]
12. Crooker, P. M., Sako, Y., and Uchida, M. (1999) Extremophiles 3, 3-9[CrossRef][Medline] [Order article via Infotrieve]
13. Adams, M. W., Perler, F. B., and Kelly, R. M. (1999) Bio/Technology 13, 662-668
14. Kawarabayasi, Y., Sawada, M., Horikoshi, H., Haikawa, Y., Hino, Y., Yamamoto, S., Sekine, M., Baba, S., Kosugi, H., Hosoyama, A., Nagai, Y., Sakai, M., Ogura, K., Otsuka, R., Nakazawa, H., Takamiya, M., Ohfuku, Y., Funahashi, T., Tanaka, T., Kudoh, Y., Yamazaki, J., Kushida, N., Oguchi, A., Aoki, K., Yoshizawa, T., Nakamura, Y., Robb, F. T., Horikoshi, K., Masuchi, Y., Shizuya, H., and Kikuchi, H. (1998) DNA Res. 5, 55-76[Abstract]
15. Kawarabayasi, Y., Sawada, M., Horikoshi, H., Haikawa, Y., Hino, Y., Yamamoto, S., Sekine, M., Baba, S., Kosugi, H., Hosoyama, A., Nagai, Y., Sakai, M., Ogura, K., Otsuka, R., Nakazawa, H., Takamiya, M., Ohfuku, Y., Funahashi, T., Tanaka, T., Kudoh, Y., Yamazaki, J., Kushida, N., Oguchi, A., Aoki, K., Yoshizawa, T., Nakamura, Y., Robb, F. T., Horikoshi, K., Masuchi, Y., Shizuya, H., and Kikuchi, H. (1998) DNA Res. 5, 147-155[CrossRef][Medline] [Order article via Infotrieve]
16. Ishikawa, K., Ishida, H., Koyama, Y., Kawarabayasi, Y., Kawahara, J., Matsui, E., and Matsui, I. (1998) J. Biol. Chem. 273, 17726-17731[Abstract/Free Full Text]
17. Laemmli, U. K. (1970) Nature 227, 680-682[CrossRef][Medline] [Order article via Infotrieve]
18. Kawaguchi, S., Nobe, Y., Yasuoka, J., Wakamiya, T., Kusumoto, S., and Kuramitsu, S. (1997) J. Biochem. (Tokyo) 122, 55-63[Abstract/Free Full Text]
19. Kuramitsu, S., Hiromi, K., Hayashi, H., Morino, Y., and Kagamiyama, H. (1990) Biochemistry 29, 5469-5476[CrossRef][Medline] [Order article via Infotrieve]
20. Fersht, A. (1985) Enzyme Structure and Mechanism , 2nd Ed. , pp. 311-346, W. H. Freeman and Company, New York
21. Karmen, A., Wroeblewski, F., and LaDue, J. S. (1955) J. Clin. Invest. 34, 126-133
22. Inoue, K., Kuramitsu, S., Aki, K., Watanabe, Y., Takagi, T., Nishigai, M., Ikai, A., and Kagamiyama, H. (1988) J. Biochem. (Tokyo) 104, 777-784[Abstract/Free Full Text]
23. Spolter, P. D., and Baldridge, R. C. (1963) J. Biol. Chem. 238, 2071-2074[Free Full Text]
24. Marino, G., Nitti, G., Arnone, M. I., Sannia, G., Gambacorta, A., and De Rosa, M. (1988) J. Biol. Chem. 263, 12305-12309[Abstract/Free Full Text]
25. Brunger, A. T. (1992) X-PLOR, version 3.1 , pp. 1-269, Yale University Press, New Haven
26. Sung, M. H., Tanizawa, K., Tanaka, H., Kuramitsu, S., Kagamiyama, H., Hirotsu, K., Okamoto, A., Higuchi, T., and Soda, K. (1991) J. Biol. Chem. 266, 2567-2572[Abstract/Free Full Text]
27. Watson, R. J., and Rastogi, V. K. (1993) J. Bacteriol. 175, 1919-1928[Abstract/Free Full Text]
28. Trach, K. A., and Hoch, J. A. (1993) Mol. Microbiol. 8, 69-79[Medline] [Order article via Infotrieve]
29. Bult, C. J., White, O., Olsen, G. J., Zhou, L., Fleischmann, R. D., Sutton, G. G., Blake, J. A., FitzGerald, L. M., Clayton, R. A., Gocayne, J. D., Kerlavage, A. R., Dougherty, B. A., Tomb, J. F., Adams, M. D., Reich, C. I., Overbeek, R., Kirkness, E. F., Weinstock, K. G., Merrick, J. M., Glodek, A., Scott, J. L., Geoghagen, N. S. M., and Venter, J. C. (1996) Science 273, 1058-1073[Abstract]
30. Cubellis, M. V., Rozzo, C., Nitti, G., Arnone, M. I., Marino, G., and Sannia, G. (1989) Eur. J. Biochem. 186, 375-381[Medline] [Order article via Infotrieve]
31. Rettenmeier, R., Natt, E., Zentgraf, H., and Scherer, G. (1990) Nucleic Acids Res. 18, 3853-3861[Abstract/Free Full Text]
32. Grange, T., Guenet, C., Dietrich, J. B., Chasserot, S., Fromont, M., Befort, N., Jami, J., Beck, G., and Pictet, R. (1985) J. Mol. Biol. 184, 347-350[CrossRef][Medline] [Order article via Infotrieve]
33. Bontempi, E. J., Bau, J., Aslund, L., Porcel, B., Segura, E. L., Henriksson, J., Orn, A., Pettersson, U., and Ruiz, A. M. (1993) Mol. Biochem. Parasitol. 59, 253-262[CrossRef][Medline] [Order article via Infotrieve]
34. Ishiguro, M., Takio, K., Suzuki, M., Oyama, R., Matsuzawa, T., and Titani, K. (1991) Biochemistry 30, 10451-10457[CrossRef][Medline] [Order article via Infotrieve]
35. Ishiguro, M., Suzuki, M., Takio, K., Matsuzawa, T., and Titani, K. (1991) Biochemistry 30, 6048-6053[CrossRef][Medline] [Order article via Infotrieve]
36. Son, D., and Sugiyama, T. (1992) Plant Mol. Biol. 20, 705-713[CrossRef][Medline] [Order article via Infotrieve]
37. Nei, M. (1987) Molecular Evolutionary Genetics , pp. 293-298, Columbia University Press, New York
38. Kuramitsu, S., Okuno, S., Ogawa, T., Ogawa, H., and Kagamiyama, H. (1985) J. Biochem. (Tokyo) 97, 1259-1262[Abstract/Free Full Text]
39. Hayashi, H., Inoue, K., Nagata, T., Kuramitsu, S., and Kagamiyama, H. (1993) Biochemistry 32, 12229-12239[CrossRef][Medline] [Order article via Infotrieve]
40. Kuramitsu, S., Inoue, K., Ogawa, T., Ogawa, H., and Kagamiyama, H. (1985) Biochem. Biophys. Res. Commun. 133, 134-139[CrossRef][Medline] [Order article via Infotrieve]
41. Oue, S., Okamoto, A., Nakai, Y., Nakahira, M., Shibatani, T., Hayashi, H., and Kagamiyama, H. (1997) J. Biochem. (Tokyo) 121, 161-171[Abstract/Free Full Text]
42. Sung, M., Tanizawa, K., Tanaka, H., Kuramitsu, S., Kagamiyama, H., and Soda, K. (1990) J. Bacteriol. 172, 1345-1351[Abstract/Free Full Text]
43. Andersson, S. M., and Pispa, J. P. (1982) Clin. Chim. Acta 125, 117-123[CrossRef][Medline] [Order article via Infotrieve]
44. Hargrove, J. L., Scoble, H. A., Mathews, W. R., Braumstark, B. R., and Biemann, K. (1989) J. Biol. Chem. 264, 45-53[Abstract/Free Full Text]
45. Montemartini, M., Santome, J. A., Cazzulo, J. J., and Nowicki, C. (1993) Biochem. J. 292, 901-906
46. Adams, M. W. W. (1992) Adv. Inorg. Chem. 38, 341-396
47. Park, J.-B., Fan, C., Hoffman, B. M., and Adams, M. W. W. (1991) J. Biol. Chem. 266, 19351-19356[Abstract/Free Full Text]
48. Klump, H., Di Ruggiero, J., Kessel, M., Park, J.-B., Adams, M. W. W., and Robb, F. T. (1992) J. Biol. Chem. 267, 22681-22685[Abstract/Free Full Text]
49. Kabsch, W., and Sander, C. (1983) Biopolymers 22, 2577-2637[CrossRef][Medline] [Order article via Infotrieve]
50. Rhee, S., Silva, M. M., Hyde, C. C., Rogers, P. H., Metzler, C. M., Metzler, D. E., and Arnone, A. (1997) J. Biol. Chem. 272, 17293-17302[Abstract/Free Full Text]
51. Chen, Y. H., Yang, J. T., and Martinez, H. M. (1972) Biochemistry 11, 4120-4131[CrossRef][Medline] [Order article via Infotrieve]
52. Andreotti, G., Cubellis, M. V., Nitti, G., Sannia, G., Mai, X., Adams, M. W. W., and Marino, G. (1995) Biochim. Biophys. Acta 1247, 90-96[CrossRef][Medline] [Order article via Infotrieve]
53. Nishio, M., Umezawa, Y., Hiroto, M., and Takeuchi, Y. (1995) Tetrahedron 51, 8665-8701[CrossRef]
54. Miyazawa, K., Kawaguchi, S., Okamoto, A., Kato, R., Ogawa, T., and Kuramitsu, S. (1994) J. Biochem. (Tokyo) 115, 568-577[Abstract/Free Full Text]
55. Iwasaki, M., Hayashi, H., and Kagamiyama, H. (1994) J. Biochem. (Tokyo) 115, 156-161[Abstract/Free Full Text]
56. Burley, S. K., and Petsko, G. A. (1986) J. Am. Chem. Soc. 108, 7995-8001[CrossRef]
57. Inoue, K., Kuramitsu, S., Okamoto, A., Hirotsu, K., Higuchi, T., and Kagamiyama, H. (1991) Biochemistry 30, 7796-7801[CrossRef][Medline] [Order article via Infotrieve]
58. Xing, R., and Whiteman, W. B. (1992) J. Bacteriol. 174, 541-548[Abstract/Free Full Text]


Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
F. J. Fernandez, M. C. Vega, F. Lehmann, E. Sandmeier, H. Gehring, P. Christen, and M. Wilmanns
Structural Studies of the Catalytic Reaction Pathway of a Hyperthermophilic Histidinol-phosphate Aminotransferase
J. Biol. Chem., May 14, 2004; 279(20): 21478 - 21488.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Goto, R. Omi, I. Miyahara, A. Hosono, H. Mizuguchi, H. Hayashi, H. Kagamiyama, and K. Hirotsu
Crystal Structures of Glutamine:Phenylpyruvate Aminotransferase from Thermus thermophilus HB8: INDUCED FIT AND SUBSTRATE RECOGNITION
J. Biol. Chem., April 16, 2004; 279(16): 16518 - 16525.
[Abstract] [Full Text] [PDF]


Home page
Plant CellHome page
J. T. Song, H. Lu, and J. T. Greenberg
Divergent Roles in Arabidopsis thaliana Development and Defense of Two Homologous Genes, ABERRANT GROWTH AND DEATH2 and AGD2-LIKE DEFENSE RESPONSE PROTEIN1, Encoding Novel Aminotransferases
PLANT CELL, February 1, 2004; 16(2): 353 - 366.
[Abstract] [Full Text] [PDF]


Home page
J BiochemHome page
A. Hosono, H. Mizuguchi, H. Hayashi, M. Goto, I. Miyahara, K. Hirotsu, and H. Kagamiyama
Glutamine:phenylpyruvate Aminotransferase from an Extremely Thermophilic Bacterium, Thermus thermophilus HB8
J. Biochem., December 1, 2003; 134(6): 843 - 851.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. B. Kuettner, R. Hilgenfeld, and M. S. Weiss
The Active Principle of Garlic at Atomic Resolution
J. Biol. Chem., November 22, 2002; 277(48): 46402 - 46407.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
Y. Wang, J. B. Anderson, J. Chen, L. Y. Geer, S. He, D. I. Hurwitz, C. A. Liebert, T. Madej, G. H. Marchler, A. Marchler-Bauer, et al.
MMDB: Entrez's 3D-structure database
Nucleic Acids Res., January 1, 2002; 30(1): 249 - 252.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Matsui, I.
Right arrow Articles by Harata, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Matsui, I.
Right arrow Articles by Harata, K.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement